Total Payments
$40,630
2024 Payments
$5,541
Companies
76
Transactions
2,009
Medicare Patients
2,625
Medicare Billing
$253,594
Payment Breakdown by Category
Food & Beverage$39,995 (98.4%)
Education$577.67 (1.4%)
Other$57.04 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $39,995 | 1,997 | 98.4% |
| Education | $577.67 | 8 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57.04 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $4,747 | 209 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,458 | 146 | $0 (2024) |
| PFIZER INC. | $3,768 | 212 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $2,726 | 177 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,172 | 75 | $0 (2024) |
| Amgen Inc. | $1,963 | 92 | $0 (2024) |
| ABBVIE INC. | $1,102 | 69 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,014 | 68 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $944.65 | 65 | $0 (2024) |
| ITI, Inc. | $909.36 | 36 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,541 | 233 | AstraZeneca Pharmaceuticals LP ($623.32) |
| 2023 | $6,503 | 267 | AstraZeneca Pharmaceuticals LP ($801.94) |
| 2022 | $5,579 | 232 | Teva Pharmaceuticals USA, Inc. ($762.68) |
| 2021 | $7,548 | 364 | Janssen Pharmaceuticals, Inc ($1,143) |
| 2020 | $3,559 | 214 | PFIZER INC. ($604.13) |
| 2019 | $3,745 | 234 | Janssen Pharmaceuticals, Inc ($710.93) |
| 2018 | $4,020 | 209 | Janssen Pharmaceuticals, Inc ($896.98) |
| 2017 | $4,134 | 256 | Janssen Pharmaceuticals, Inc ($720.07) |
All Payment Transactions
2,009 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: CNS | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: CNS | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 647 | 896 | $141,448 | $68,419 |
| 2022 | 11 | 644 | 902 | $125,919 | $60,708 |
| 2021 | 9 | 653 | 971 | $128,526 | $63,183 |
| 2020 | 8 | 681 | 1,088 | $144,360 | $61,285 |
Total Patients
2,625
Total Services
3,857
Medicare Billing
$253,594
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 111 | 121 | $29,282 | $17,435 | 59.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 147 | $29,360 | $11,538 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 198 | $25,740 | $10,818 | 42.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 63 | 70 | $13,370 | $7,329 | 54.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $8,730 | $5,776 | 66.2% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 79 | 166 | $14,940 | $4,853 | 32.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 41 | 47 | $4,761 | $2,796 | 58.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $3,140 | $2,515 | 80.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 33 | 39 | $5,070 | $2,154 | 42.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 12 | $3,000 | $1,991 | 66.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,100 | $990.53 | 47.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $1,955 | $223.44 | 11.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 146 | 269 | $34,990 | $14,905 | 42.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 115 | 136 | $25,976 | $14,014 | 53.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 109 | $21,670 | $9,306 | 42.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 44 | 46 | $11,132 | $6,111 | 54.9% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 113 | 188 | $12,376 | $5,752 | 46.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $4,125 | $2,837 | 68.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 56 | 56 | $5,600 | $2,773 | 49.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 28 | 35 | $4,550 | $2,357 | 51.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $2,445 | $1,260 | 51.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 11 | 12 | $1,950 | $1,240 | 63.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $1,105 | $151.68 | 13.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 277 | $36,120 | $16,214 | 44.9% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 141 | 151 | $28,841 | $16,015 | 55.5% |
About Dr. Michael Klufas, MD
Dr. Michael Klufas, MD is a Geriatric Medicine healthcare provider based in Cumberland, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205822277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Klufas, MD has received a total of $40,630 in payments from pharmaceutical and medical device companies, with $5,541 received in 2024. These payments were reported across 2,009 transactions from 76 companies. The most common payment nature is "Food and Beverage" ($39,995).
As a Medicare-enrolled provider, Klufas has provided services to 2,625 Medicare beneficiaries, totaling 3,857 services with total Medicare billing of $253,594. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Cumberland, RI
- Active Since 09/23/2005
- Last Updated 03/19/2015
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205822277
Products in Payments
- XARELTO (Drug) $4,055
- ELIQUIS (Drug) $2,505
- AUSTEDO (Drug) $1,663
- FARXIGA (Drug) $1,634
- CAPLYTA (Drug) $1,330
- JARDIANCE (Drug) $1,255
- Otezla (Drug) $1,028
- APTIOM (Drug) $1,003
- NUEDEXTA (Drug) $964.33
- LOKELMA (Drug) $848.67
- VRAYLAR (Drug) $809.62
- ENTRESTO (Drug) $760.11
- CHANTIX (Drug) $746.57
- BREZTRI (Drug) $736.79
- FREESTYLE LIBRE 3 (Device) $721.81
- Austedo XR (Drug) $684.30
- XIFAXAN (Drug) $678.49
- INGREZZA (Drug) $647.24
- Vascepa (Drug) $638.95
- INVOKANA (Drug) $613.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.